Status: current, Defined. Date: 31-Aug 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4605811000168114 | cannabidiol 2.5 mg + delta-9-tetrahydrocannabinol 2.5 mg capsule, 30 capsules (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4605821000168119 | delta-9-tetrahydrocannabinol 2.5 mg + cannabidiol 2.5 mg capsule, 30 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| delta-9-tetrahydrocannabinol 2.5 mg + cannabidiol 2.5 mg capsule, 30 | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| delta-9-tetrahydrocannabinol 2.5 mg + cannabidiol 2.5 mg capsule, 30 | has MPUU | delta-9-tetrahydrocannabinol 2.5 mg + cannabidiol 2.5 mg capsule | true | Inferred relationship | Some | 6615785 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Neuvis (THC 2.5:CBD 2.5) capsule, 30 | Is a | True | delta-9-tetrahydrocannabinol 2.5 mg + cannabidiol 2.5 mg capsule, 30 | Inferred relationship | Some |
Reference Sets
Schedule 8 medications reference set
Australian dialect reference set
Description inactivation indicator reference set
Medicinal product pack reference set
FHIR